Findings suggest LRG1 may not serve as a direct biomarker for hepatosteatosis in obese children but is negatively associated with IR and dyslipidemia. These results highlight a complex role for LRG1 in obesity-related metabolic dysfunction and support further longitudinal and pathophysiological studies.
Singin et al. (Mon,) studied this question.